My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Novavax, Inc. - Common Stock (NQ:NVAX)

7.060 -0.140 (-1.94%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Novavax, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

60 61 Next >

FDA Approves Novavax's Updated COVID Vaccine Targeting Currently Circulating Variants ↗

September 03, 2024

The FDA granted Emergency Use Authorization to Novavax's updated COVID-19 vaccine for individuals aged 12 and older. The vaccine, included in CDC recommendations, will soon be available nationwide....

Via Benzinga

Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy? ↗

August 24, 2024

Don't be too quick to jump on the Wall Street bandwagon.

Via The Motley Fool

FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot ↗

August 22, 2024

The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new formulas from Moderna and Pfizer/BioNTech. These vaccines, designed to...

Via Benzinga

Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell? ↗

August 19, 2024

Its 12-month relative strength performance is impressive, but Novavax now faces resistance.

Via Investor's Business Daily

FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch ↗

August 19, 2024

The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.

Via Benzinga

Topics ETFs

Looking Into Novavax's Recent Short Interest ↗

August 16, 2024

Via Benzinga

Market Whales and Their Recent Bets on NVAX Options ↗

July 26, 2024

Via Benzinga

COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit ↗

August 08, 2024

Novavax reported Q2 2024 revenue of $415 million, missing estimates, with net income rising to $162 million. EPS increased to $0.99, below expectations. The company revised its 2024 revenue guidance to...

Via Benzinga

NVAX Stock Earnings: Novavax Misses EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

NVAX stock results show that Novavax missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 3 ↗

August 03, 2024

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of July 29 through Aug. 2.

Via Talk Markets

Where Will Novavax Be in 5 Years? ↗

August 03, 2024

Its been a good year so far for the biotech, but how long can it keep the momentum going?

Via The Motley Fool

What's Going On With Novavax (NVAX) Stock? ↗

August 01, 2024

Novavax shares are trading lower by 5.5% Thursday morning. Shares of several vaccine makers are trading lower after Moderna revised its 2024 expectations.

Via Benzinga

What's Going On With Novavax Shares Today? ↗

July 25, 2024

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Thursday. Here's what you need to know.

Via Benzinga

Looking Into Novavax's Recent Short Interest ↗

July 24, 2024

Via Benzinga

Here's How Much $100 Invested In Novavax 5 Years Ago Would Be Worth Today ↗

July 18, 2024

Via Benzinga

Moderna Slashes Its Outlook On 'Very Low' European Sales Despite Quarterly Beat ↗

August 01, 2024

Moderna delivered nearly double the sales analysts expected in the second quarter.

Via Investor's Business Daily

JPMorgan Just Cut Its Price Target on These 3 Stocks: July 31, 2024 ↗

July 31, 2024

Analysts from JPMorgan Chase have expressed their concern about the outlook for these stocks with lowered price targets.

Via InvestorPlace

JPMorgan Just Issued a Warning on Novavax (NVAX) Stock ↗

July 30, 2024

Novavax has inked a key vaccine deal with Sanofi, but NVAX stock is down after JPMorgan warned about overvaluation concerns.

Via InvestorPlace

Stocks Mixed After Job Openings, Consumer Data ↗

July 30, 2024

Stocks are mixed midday, as the Federal Reserve's two-day policy meeting gets underway, with plenty of earnings and economic data for Wall Street to unpack in the meantime.

Via Talk Markets

Topics Economy

Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 30, 2024

Via Benzinga

$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today ↗

July 16, 2024

Via Benzinga

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 30, 2024

Via Benzinga

Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗

July 30, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 23, 2024

Via Benzinga

Biotech Bull Market Is Intact But SMIDs Are Too Volatile ↗

July 22, 2024

It was another wild week for the market as it had to contend with a lot of news.

Via Talk Markets

COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch ↗

July 18, 2024

Over half of US states have high levels of Covid-19 in wastewater as President Biden isolates with virus. New vaccines expected by Sept.

Via Benzinga

The Lazarus Effect: 3 ‘Dead’ Stocks That Could Rise From the Ashes ↗

July 16, 2024

These companies, thought dead, could pull a Lazarus and rise from the ashes, making them stocks to buy for a comeback.

Via InvestorPlace

UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday ↗

July 16, 2024

Via Benzinga

What's Going On With Novavax Shares Monday? ↗

July 15, 2024

Novavax, Inc. (NASDAQ: NVAX) shares are moving higher on Monday. Here's what you need to know.

Via Benzinga

Novavax’s Second Act: How a Fallen COVID Star Could Rise from the Ashes ↗

July 03, 2024

After pulling back following May's "Sanofi surge," don't rule out the potential for further needle-moving news with Novavax stock.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

60 61 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.